User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 2 results.
    • Journal article
    Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
    Löwenberg, Bob Pabst, Thomas Maertens, Johan Gradowska, Patrycja Biemond, Bart J Spertini, Olivier Vellenga, Edo Griskevicius, Laimonas Tick, Lidwine W Jongen-Lavrencic, Mojca van Marwijk Kooy, Marinus Vekemans, Marie-Christiane[UCL] van der Velden, Walter J F M Beverloo, Berna Michaux, Lucienne Graux, Carlos[UCL] Deeren, Dries de Weerdt, Okke van Esser, Joost W J Bargetzi, Mario Klein, Saskia K Gadisseur, Alain Westerweel, Peter E Veelken, Hendrik Gregor, Michael Silzle, Tobias van Lammeren-Venema, Daniëlle Moors, Ine Breems, Dimitri A Hoogendoorn, Mels Legdeur, Marie-Cecile J C Fischer, Thomas Kuball, Juergen Cornelissen, Jan Porkka, Kimmo Juliusson, Gunnar Meyer, Peter Höglund, Martin Gjertsen, Bjorn T Janssen, Jeroen J W M Huls, Gerwin Passweg, Jakob Cloos, Jacqueline Valk, Peter J M van Elssen, Catharina H M J Manz, Markus G Floisand, Yngvar Ossenkoppele, Gert J (2021) Blood advances — Vol. 5, no. 4, p. 1110-1121 (2021)
    • Journal article
    Oral cladribine for B-cell chronic lymphocytic leukaemia: Report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients
    Karlsson, Karin Stromberg, Mats Liliemark, Jan Delannoy, André[UCL] Johnson, S.A.N. Porwit, Anja Kimby, Eva Larfars, Gerd Cristiansen, Ilse Nilsson, Göran Celsing, Fredrik Sundstrom, Gunnel Luthman, Mikaela Tidefelt, Ulf Wallvik, Jonas Juliusson, Gunnar (2002) British Journal of Haematology — Vol. 116, no. 3, p. 538-548 (2002)